Koselugo 10 mg
Koselugo 10 mg is a medicine authorised by Swissmedic under authorisation number 67410. The authorisation holder is Alexion Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 July 2022 and the authorisation is limited until 10 March 2030. ATC code L01EE04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67410 |
|---|---|
| Name | Koselugo 10 mg |
| Full name | Koselugo 10 mg, Hartkapseln |
| Authorisation holder | Alexion Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EE04 |
| First authorisation | 29 July 2022 |
| Authorisation validity | 10 March 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Koselugo 10 mg, Hartkapseln | A | 29 July 2022 |
| 2 | Koselugo 25 mg, Hartkapseln | A | 29 July 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Kapsel(n) | L01EE04 | 07.16.1. | A |
| 2 | 60 | Kapsel(n) | L01EE04 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Koselugo 10 mg authorised in Switzerland?
Yes. Koselugo 10 mg is authorised by Swissmedic under authorisation number 67410, data as of 01 September 2026. The authorisation is limited until 10 March 2030.
Which dispensing category does Koselugo 10 mg have?
Koselugo 10 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Koselugo 10 mg?
The authorisation holder is Alexion Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.